Consumer Products
Cymbiotika
A science-backed, premium wellness platform.

Overview
Cymbiotika makes vitamins, minerals and specialty supplements for health, longevity and vitality, using liposomal delivery technology to improve nutrient absorption. It sells direct-to-consumer, by subscription and through national retail.
Why we invested
- Recurring revenue from a loyal subscription base
- Proprietary liposomal delivery technology
- National retail expansion on top of a strong direct-to-consumer business
More case studies
Case study · Business & Professional Services

Scaled to $100M+ revenue in five years through 10 add-on acquisitions.
15Acquisitions to date
2Partial realizations to date
John Signa’s roleFounder, CEO & Executive Board Member
View the value creation timeline → Case study · Industrial Services4.7x EBITDA growth from first investment.
30%3-year organic CAGR
+590 bpsEBITDA margin expansion through revenue mix shift
John Signa’s roleCo-founder
View the value creation timeline →Let’s connect
Building something worth backing?
Talk to a team that has founded, scaled and led companies like yours. Every conversation is confidential.
